<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85637">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01868750</url>
  </required_header>
  <id_info>
    <org_study_id>16544</org_study_id>
    <nct_id>NCT01868750</nct_id>
  </id_info>
  <brief_title>Phase II Pre-operative Vitamin D Supplementation to Prevent Post-thyroidectomy Hypocalcemia</brief_title>
  <official_title>A Phase 2, Placebo-controlled, Randomized Study to Evaluate the Effect of Pre-operative Vitamin D Supplementation on Hypocalcemia Following Total or Near-total Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>David Shonka, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the major side effects of surgery to remove the thyroid gland is transient (lasting
      for a short time) low calcium levels in the blood, or &quot;hypocalcemia.&quot; Low calcium levels can
      cause symptoms such as numbness around the mouth, tingling or cramping in the hands and
      feet, severe muscle spasms, inability to breathe, or heart rhythm (heart beat)
      abnormalities. Severe symptoms are life threatening, so it is important to start the
      management of these symptoms in the hospital. Treating low calcium levels sometimes require
      patients to spend a few extra days in the hospital.

      The human body needs vitamin D to function and stay healthy. Vitamin D helps the body get
      the calcium needed to make strong bones and teeth. The purpose of this study is to determine
      if taking vitamin D before surgery to remove the thyroid gland affects whether or not you
      may have low calcium levels after your surgery and to test the hypothesis that those who are
      given the Vitamin D before surgery will have decreased hypocalcemia and a shortened hospital
      stay.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Measure of Serum Calcium Levels</measure>
    <time_frame>2-5 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Serum calcium levels will be evaluated at routine intervals to identify incidences of hypocalcemia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evidence of Hypocalcemia</measure>
    <time_frame>2-5 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measuring hypocalcemia symptoms, requirements for IV calcium, and extended hospital stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">53</enrollment>
  <condition>Thyroid Nodules</condition>
  <condition>Hypocalcemia</condition>
  <arm_group>
    <arm_group_label>Vitamin D (Calcitriol)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Calcitriol, 1.0ug twice daily for 7 days prior to surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo pill taken twice daily for 7 days prior to surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcitriol</intervention_name>
    <description>1.0ug twice daily for 7 days before surgery</description>
    <arm_group_label>Vitamin D (Calcitriol)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control Pill</intervention_name>
    <description>placebo pill taken twice daily for 7 days before surgery</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient referred for thyroidectomy

          -  Agreement to use contraception prior to and during the study

        Exclusion Criteria:

          -  Hypercalcemia (&gt;10.5mg/dL)

          -  Chronic kidney or parathyroid disease

          -  Cardiac or Central Nervous System disease

          -  Pregnant or breastfeeding women
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David C Shonka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David C Shonka, MD</last_name>
    <phone>434-924-1565</phone>
    <email>dcs5z@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>David C Shonka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Jameson, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 19, 2013</lastchanged_date>
  <firstreceived_date>May 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>David Shonka, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypocalcemia</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
